SK5095A3 - Two component fibrin-glue composition for improving in vitro fertilization - Google Patents
Two component fibrin-glue composition for improving in vitro fertilizationInfo
- Publication number
- SK5095A3 SK5095A3 SK50-95A SK5095A SK5095A3 SK 5095 A3 SK5095 A3 SK 5095A3 SK 5095 A SK5095 A SK 5095A SK 5095 A3 SK5095 A3 SK 5095A3
- Authority
- SK
- Slovakia
- Prior art keywords
- component
- improving
- glue composition
- vitro fertilization
- fibrin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
A two component fibrin-glue composition comprising the components A and B, wherein component A comprises fibrinogen and a protease inhibitor, component B comprises a proteolytic enzyme being capable of cleaving specifically fibrinogen and causing formation of the fibrin polymer and additionally ingredients for culturing embryonic cells of mammals in one or both of the components A and B.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92112295 | 1992-07-18 | ||
EP93105298 | 1993-03-30 | ||
PCT/EP1993/001797 WO1994002182A1 (en) | 1992-07-18 | 1993-07-09 | A two component fibrin-glue composition for improving in vitro fertilization |
Publications (1)
Publication Number | Publication Date |
---|---|
SK5095A3 true SK5095A3 (en) | 1995-07-11 |
Family
ID=26131003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK50-95A SK5095A3 (en) | 1992-07-18 | 1993-07-09 | Two component fibrin-glue composition for improving in vitro fertilization |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPH08502035A (en) |
KR (1) | KR950702434A (en) |
AT (1) | ATE151295T1 (en) |
AU (1) | AU4566893A (en) |
CA (1) | CA2140427A1 (en) |
CZ (1) | CZ5495A3 (en) |
DE (1) | DE69309685T2 (en) |
FI (1) | FI950194L (en) |
HU (1) | HUT71873A (en) |
IL (1) | IL106293A0 (en) |
SK (1) | SK5095A3 (en) |
WO (1) | WO1994002182A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994022503A1 (en) * | 1993-03-30 | 1994-10-13 | Opperbas Holding B.V. | Two component fibrin glue |
US5411885A (en) * | 1993-12-17 | 1995-05-02 | New York Blood Center, Inc. | Methods for tissue embedding and tissue culturing |
AU3145795A (en) * | 1994-07-26 | 1996-02-22 | Children's Medical Center Corporation | Fibrin-cell suspension for construction of new tissue |
DE69629010T2 (en) * | 1995-01-16 | 2004-04-15 | Baxter International Inc., Deerfield | SELF-SUPPORTING AREA MADE OF CROSS-LINKED FIBRINE FOR INHIBITING POST-OPERATIVE ADHESIONS |
WO1999025782A2 (en) * | 1997-11-17 | 1999-05-27 | Haemacure Corporation | Fibrin sealants or adhesives comprising a hyaluronic acid derivative material |
BE1012536A3 (en) | 1998-11-04 | 2000-12-05 | Baxter Int | Element with a layer fibrin its preparation and use. |
US7135027B2 (en) | 2002-10-04 | 2006-11-14 | Baxter International, Inc. | Devices and methods for mixing and extruding medically useful compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT369990B (en) * | 1981-07-28 | 1983-02-25 | Immuno Ag | METHOD FOR PRODUCING A TISSUE ADHESIVE |
US4904259A (en) * | 1988-04-29 | 1990-02-27 | Samuel Itay | Compositions and methods for repair of cartilage and bone |
CH681693A5 (en) * | 1991-02-28 | 1993-05-14 | Pentapharm Ag | |
SE9101853D0 (en) * | 1991-06-17 | 1991-06-17 | Jonas Wadstroem | IMPROVED TISSUE ASHESIVE |
-
1993
- 1993-07-09 WO PCT/EP1993/001797 patent/WO1994002182A1/en not_active Application Discontinuation
- 1993-07-09 AU AU45668/93A patent/AU4566893A/en not_active Abandoned
- 1993-07-09 IL IL93106293A patent/IL106293A0/en unknown
- 1993-07-09 FI FI950194A patent/FI950194L/en unknown
- 1993-07-09 KR KR1019950700191A patent/KR950702434A/en not_active Withdrawn
- 1993-07-09 SK SK50-95A patent/SK5095A3/en unknown
- 1993-07-09 HU HU9500141A patent/HUT71873A/en unknown
- 1993-07-09 DE DE69309685T patent/DE69309685T2/en not_active Revoked
- 1993-07-09 JP JP6503912A patent/JPH08502035A/en not_active Ceased
- 1993-07-09 CZ CZ9554A patent/CZ5495A3/en unknown
- 1993-07-09 AT AT93915861T patent/ATE151295T1/en active
- 1993-07-09 CA CA002140427A patent/CA2140427A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FI950194A7 (en) | 1995-01-17 |
CA2140427A1 (en) | 1994-02-03 |
CZ5495A3 (en) | 1995-06-14 |
WO1994002182A1 (en) | 1994-02-03 |
DE69309685T2 (en) | 1997-10-16 |
HUT71873A (en) | 1996-02-28 |
AU4566893A (en) | 1994-02-14 |
KR950702434A (en) | 1995-07-29 |
ATE151295T1 (en) | 1997-04-15 |
JPH08502035A (en) | 1996-03-05 |
FI950194A0 (en) | 1995-01-17 |
DE69309685D1 (en) | 1997-05-15 |
HU9500141D0 (en) | 1995-03-28 |
FI950194L (en) | 1995-01-17 |
IL106293A0 (en) | 1993-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2073195A (en) | High-alkaline protease and its use | |
ATE376061T1 (en) | HIGH ALKALINE SERINE PROTEASES | |
ES8801552A1 (en) | Fibrinolytic enzyme. | |
ATE77650T1 (en) | ENZYMATIC DETERGENT COMPOSITION. | |
EP0602173A4 (en) | Topical fibrinogen complex. | |
BG103977A (en) | Low molecular rotamase enzymic activity inhibitors | |
GR3024181T3 (en) | N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors. | |
CY2572B1 (en) | Serum free medium | |
AU6536394A (en) | Two component fibrin glue | |
GR3031646T3 (en) | Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors. | |
AR014879A1 (en) | WHITENING ENZYMES | |
SK5095A3 (en) | Two component fibrin-glue composition for improving in vitro fertilization | |
ES8708008A1 (en) | Detergent composition containing an enzyme and a glycoside surfactant. | |
ES2091280T3 (en) | LIQUID DETERGENT COMPOSITION CONTAINING LIPASE AND PROTEASE. | |
GR920100244A (en) | Phosphate-containing powder automatic dishwashing composition with enzymes. | |
IE830480L (en) | Fibrinolytic enzymes | |
CA2160228A1 (en) | Secondary (2,3) alkyl sulfate surfactants in stable enzyme-containing detergent compositions | |
EP0218479A3 (en) | Reagent and process | |
AU2353688A (en) | Modified tissue plasminogen activator | |
NO950171L (en) | Two-component fibrin glue mixture to improve in vitro fertility | |
WO1998016604A3 (en) | Detergent compositions containing isopeptidase | |
BG103305A (en) | Intermediate compounds for the preparation of hiv protease inhibitors and methods for the preparation of hiv protease inhibitors | |
EP0292326A3 (en) | Modified enzyme | |
AR002903A1 (en) | NOVEL PROTEOLYTIC ENZYMES. | |
EP0400611A3 (en) | Aminoacetophenone derivatives and method for determination of enzyme activity using the same |